Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental cyclophosphamide poisoning |
Causative agent (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Intentional cyclophosphamide poisoning |
Causative agent (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
intoxication par le cyclophosphamide d'intention indéterminée |
Causative agent (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide adverse reaction |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Allergy to cyclophosphamide (finding) |
Causative agent (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide overdose |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Accidental cyclophosphamide overdose |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Intentional cyclophosphamide overdose |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
surdose de cyclophosphamide d'intention indéterminée |
Causative agent (attribute) |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 20mg/mL infusion solution 200mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 20mg/mL infusion solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 20mg/mL infusion solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 200mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 500mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 1g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 2g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 1000mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Product containing cyclophosphamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Poisoning by cyclophosphamide |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing cyclophosphamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 200mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 1g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 500mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Accidental cyclophosphamide poisoning |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Intentional cyclophosphamide poisoning |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Allergy to cyclophosphamide (finding) |
Causative agent (attribute) |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide therapy (procedure) |
Direct substance |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
2 |
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy) |
Direct substance |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
8 |
Cyclophosphamide monohydrate (substance) |
Is a |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|
Cyclophosphamide 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing only cyclophosphamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing only cyclophosphamide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy |
Direct substance |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
5 |
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 200 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 200 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 1 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide 1 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
1 |
Cyclophosphamide anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cyclophosphamide (substance) |
Inferred relationship |
Some |
|